TapewireFind a company

person · Reporting owner

Dudum Andrew

Disclosed activity across 1 company

Tapewire entity
18974
SEC CIK
0001837796

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Director · Chief Executive Officer · 10% ownerAugust 25, 2026August 28, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date August 25, 2026 · Filed August 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT0 Reported balance After 2026-08-25 transaction · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT463,289 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 463,289

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Legacy 2021 Trust103,406 Reported balance After 2026-08-27 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Class A Common StockSEC Table I · non-derivativeDirect1,033,177 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,033,177

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015573,202 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 573,202

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2025 GRAT dated 5-27-202542,993 Reported balance Holding disclosure · report date 2026-08-25 · row 6 Holding and transaction disclosures are not merged.
1 source row

Row 6 · Balance 42,993

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Community Property Trust470,457 Reported balance Holding disclosure · report date 2026-08-25 · row 7 Holding and transaction disclosures are not merged.
1 source row

Row 7 · Balance 470,457

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022791,117 Reported balance Holding disclosure · report date 2026-08-25 · row 8 Holding and transaction disclosures are not merged.
1 source row

Row 8 · Balance 791,117

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-20212,214,769 Reported balance Holding disclosure · report date 2026-08-25 · row 9 Holding and transaction disclosures are not merged.
1 source row

Row 9 · Balance 2,214,769

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family 2021 Trust3,004,071 Reported balance Holding disclosure · report date 2026-08-25 · row 10 Holding and transaction disclosures are not merged.
1 source row

Row 10 · Balance 3,004,071

Filing footnotes · ownership attribution and instrument terms

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 28, 2024 Filed Mar 1, 2024 21:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 GrantRestricted Stock Unit · Derivative 1,192,477 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · derivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,192,477

Underlying: Class A Common Stock · 1,192,477 shares

Expires not disclosed

F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
February 14, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 77,382 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · derivative · entry 9

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,481,023

Underlying: Class A Common Stock · 77,382 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
February 14, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 77,382 $9.90 $766,267.52
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.71 - $10.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 14, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 77,382 $2.43 $188,038.26
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 97,208 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · derivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,558,405

Underlying: Class A Common Stock · 97,208 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 97,208 $9.58 $931,009.62
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.15 - $9.79. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 97,208 $2.43 $236,215.44
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,861

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
February 12, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 81,541 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · derivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,655,613

Underlying: Class A Common Stock · 81,541 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
February 12, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 81,541 $9.98 $814,040.11
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.82 - $10.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
February 12, 2024 Filed Feb 15, 2024 01:50 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 81,541 $2.43 $198,144.63
Disclosure

SEC source: 0001773751-24-000012 · wk-form4_1707961821.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
January 29, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 15,100 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · derivative · entry 9

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,737,154

Underlying: Class A Common Stock · 15,100 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
January 29, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 15,100 $9.01 $136,023.82
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.03. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 29, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 15,100 $2.43 $36,693.00
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 52,940 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · derivative · entry 8

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,752,254

Underlying: Class A Common Stock · 52,940 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 52,940 $9.11 $482,113.99
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.205. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 26, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 52,940 $2.43 $128,644.20
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 127,688 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · derivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,805,194

Underlying: Class A Common Stock · 127,688 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 127,688 $9.08 $1,159,343.20
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.205. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 23:40 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 127,688 $2.43 $310,281.84
Disclosure

SEC source: 0001773751-24-000006 · wk-form4_1706571592.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 179,341

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
December 29, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 21,432 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,932,882

Underlying: Class A Common Stock · 21,432 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
December 29, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 21,432 $9.06 $194,223.21
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.01 - $9.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 29, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 21,432 $2.43 $52,079.76
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 25,750 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · derivative · entry 18

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,954,314

Underlying: Class A Common Stock · 25,750 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 25,750 $9.01 $232,002.35
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.035. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 28, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 25,750 $2.43 $62,572.50
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 7,700 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · derivative · entry 17

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,980,064

Underlying: Class A Common Stock · 7,700 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 7,700 $9.02 $69,462.47
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 27, 2023 Filed Dec 29, 2023 23:09 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 7,700 $2.43 $18,711.00
Disclosure

SEC source: 0001773751-23-000323 · wk-form4_1703891337.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,353

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 9,923 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 21

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,924

Underlying: Class A Common Stock · 9,923 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 197 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 20

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198

Underlying: Class A Common Stock · 197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,289 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,446

Underlying: Class A Common Stock · 18,289 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,789 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 18

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,945

Underlying: Class A Common Stock · 1,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 3,575 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 17

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,877

Underlying: Class A Common Stock · 3,575 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 107 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 16

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 534

Underlying: Class A Common Stock · 107 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 7,330 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,650

Underlying: Class A Common Stock · 7,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,242 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,178

Underlying: Class A Common Stock · 35,242 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,446 $0.00 $0.00
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · derivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 460,805

Underlying: Class A Common Stock · 35,446 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 60,245 $8.45 $509,070.25
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,653

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 21:56 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 111,898 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-23-000306 · wk-form4_1703022979.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 24,300 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000284 · wk-form4_1701732445.xml · derivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,987,764

Underlying: Class A Common Stock · 24,300 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 24,300 $9.03 $219,375.54
Disclosure

SEC source: 0001773751-23-000284 · wk-form4_1701732445.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 01, 2023 Filed Dec 4, 2023 23:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 24,300 $2.43 $59,049.00
Disclosure

SEC source: 0001773751-23-000284 · wk-form4_1701732445.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
December 01, 2023 Filed Dec 15, 2023 13:57 UTC Amendment Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 24,300 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000289 · wk-form4a_1702648666.xml · derivative · entry 16

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,987,764

Underlying: Class A Common Stock · 24,300 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
December 01, 2023 Filed Dec 15, 2023 13:57 UTC Amendment Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 24,300 $9.03 $219,375.54
Disclosure

SEC source: 0001773751-23-000289 · wk-form4a_1702648666.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 01, 2023 Filed Dec 15, 2023 13:57 UTC Amendment Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 24,300 $2.43 $59,049.00
Disclosure

SEC source: 0001773751-23-000289 · wk-form4a_1702648666.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 3,800 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000284 · wk-form4_1701732445.xml · derivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,012,064

Underlying: Class A Common Stock · 3,800 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,800 $9.01 $34,220.52
Disclosure

SEC source: 0001773751-23-000284 · wk-form4_1701732445.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 23:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 3,800 $2.43 $9,234.00
Disclosure

SEC source: 0001773751-23-000284 · wk-form4_1701732445.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
November 30, 2023 Filed Dec 15, 2023 13:57 UTC Amendment Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 3,800 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-23-000289 · wk-form4a_1702648666.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,012,064

Underlying: Class A Common Stock · 3,800 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
November 30, 2023 Filed Dec 15, 2023 13:57 UTC Amendment Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 3,800 $9.01 $34,220.52
Disclosure

SEC source: 0001773751-23-000289 · wk-form4a_1702648666.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.